Pamela D. Jones

760 total citations
14 papers, 369 citations indexed

About

Pamela D. Jones is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Molecular Biology. According to data from OpenAlex, Pamela D. Jones has authored 14 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Small Animals and 3 papers in Molecular Biology. Recurrent topics in Pamela D. Jones's work include Veterinary Oncology Research (10 papers), Infectious Diseases and Mycology (7 papers) and Oral and Maxillofacial Pathology (3 papers). Pamela D. Jones is often cited by papers focused on Veterinary Oncology Research (10 papers), Infectious Diseases and Mycology (7 papers) and Oral and Maxillofacial Pathology (3 papers). Pamela D. Jones collaborates with scholars based in United States, United Kingdom and Australia. Pamela D. Jones's co-authors include Mary K. Klein, Paul R. Hess, Deborah A. Grosenbaugh, Maribeth H. Johnson, Nicole F. Leibman, Jedd D. Wolchok, Ilene D. Kurzman, Karri A. Meleo, Philip J. Bergman and Barbara E. Kitchell and has published in prestigious journals such as Journal of Cellular and Molecular Medicine, Journal of Veterinary Internal Medicine and American Journal of Veterinary Research.

In The Last Decade

Pamela D. Jones

14 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pamela D. Jones United States 10 222 124 111 92 79 14 369
Karri A. Meleo United States 6 193 0.9× 118 1.0× 100 0.9× 73 0.8× 53 0.7× 7 277
M. Lagadic France 8 174 0.8× 51 0.4× 94 0.8× 62 0.7× 49 0.6× 17 276
Barbara C. Rütgen Austria 14 308 1.4× 124 1.0× 134 1.2× 138 1.5× 126 1.6× 41 504
Alexandra Malbon United Kingdom 12 103 0.5× 31 0.3× 58 0.5× 67 0.7× 87 1.1× 36 346
D. Caliari Italy 10 192 0.9× 20 0.2× 97 0.9× 41 0.4× 82 1.0× 14 305
K. W. Head United Kingdom 8 150 0.7× 63 0.5× 61 0.5× 37 0.4× 63 0.8× 11 285
Gerald W. Gough United Kingdom 10 66 0.3× 122 1.0× 18 0.2× 83 0.9× 231 2.9× 11 489
Laura Dill Morton United States 8 34 0.2× 115 0.9× 42 0.4× 18 0.2× 98 1.2× 15 336
Yeganeh Talebkhan Iran 13 70 0.3× 215 1.7× 61 0.5× 23 0.3× 118 1.5× 40 523
Shruthi Naik United States 14 99 0.4× 96 0.8× 14 0.1× 551 6.0× 219 2.8× 26 712

Countries citing papers authored by Pamela D. Jones

Since Specialization
Citations

This map shows the geographic impact of Pamela D. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pamela D. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pamela D. Jones more than expected).

Fields of papers citing papers by Pamela D. Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pamela D. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pamela D. Jones. The network helps show where Pamela D. Jones may publish in the future.

Co-authorship network of co-authors of Pamela D. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Pamela D. Jones. A scholar is included among the top collaborators of Pamela D. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pamela D. Jones. Pamela D. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Musser, Margaret, et al.. (2024). Response to tigilanol tiglate in dogs with mast cell tumors. Journal of Veterinary Internal Medicine. 38(6). 3162–3169. 2 indexed citations
2.
Berlato, Davide, Craig A. Clifford, Laura D. Garrett, et al.. (2021). Value, Limitations, and Recommendations for Grading of Canine Cutaneous Mast Cell Tumors: A Consensus of the Oncology-Pathology Working Group. Veterinary Pathology. 58(5). 858–863. 25 indexed citations
3.
Reddell, Paul, John M. Morton, Pamela D. Jones, et al.. (2021). Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate. Journal of Veterinary Internal Medicine. 35(1). 430–441. 15 indexed citations
4.
White, Julie, Chad M. Johannes, John M. Morton, et al.. (2020). Randomized controlled clinical study evaluating the efficacy and safety of intratumoral treatment of canine mast cell tumors with tigilanol tiglate (EBC-46). Journal of Veterinary Internal Medicine. 35(1). 415–429. 35 indexed citations
5.
Jones, Pamela D., et al.. (2020). Recurrence-free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate. Journal of Veterinary Internal Medicine. 35(1). 451–455. 14 indexed citations
6.
Thamm, Douglas H., Anne C. Avery, Davide Berlato, et al.. (2019). Prognostic and predictive significance of KIT protein expression and c‐kit gene mutation in canine cutaneous mast cell tumours: A consensus of the Oncology‐Pathology Working Group. Veterinary and Comparative Oncology. 17(4). 451–455. 21 indexed citations
7.
Cutrera, Jeffry J., et al.. (2015). Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro‐chemo‐gene therapy. Journal of Cellular and Molecular Medicine. 19(3). 664–675. 21 indexed citations
8.
Cutrera, Jeffry J., et al.. (2014). Safety and Efficacy of Tumor-Targeted Interleukin 12 Gene Therapy in Treated and Non-Treated, Metastatic Lesions. Current Gene Therapy. 15(1). 44–54. 18 indexed citations
9.
Cutrera, Jeffry J., et al.. (2014). Managing Local Swelling Following Intratumoral Electro-Chemo-Gene Therapy. Methods in molecular biology. 233–239. 1 indexed citations
10.
Vail, David M., Douglas H. Thamm, Jeffrey N. Bryan, et al.. (2011). Biological activity of toceranib (Palladia) in canine anal gland anal SAC adenocarcinoma (AGASACA). Veterinary and Comparative Oncology. 9(1). 1 indexed citations
11.
Grosenbaugh, Deborah A., Philip J. Bergman, Mary K. Klein, et al.. (2011). Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. American Journal of Veterinary Research. 72(12). 1631–1638. 160 indexed citations
12.
Charney, Sarah C., Wendell R. Lutz, Mary K. Klein, & Pamela D. Jones. (2009). EVALUATION OF A HEAD‐REPOSITIONER AND Z‐PLATE SYSTEM FOR IMPROVED ACCURACY OF DOSE DELIVERY. Veterinary Radiology & Ultrasound. 50(3). 323–329. 12 indexed citations
13.
Hintermeister, John G., Pamela D. Jones, Walter Hoffmann, et al.. (2008). Measurement of serum carboxyterminal cross-linked telopeptide of type I collagen concentration in dogs with osteosarcoma. American Journal of Veterinary Research. 69(11). 1481–1486. 1 indexed citations
14.
Jones, Pamela D., Louis‐Philippe de Lorimier, Barbara E. Kitchell, & John M. Losonsky. (2003). Gemcitabine as a Radiosensitizer for Nonresectable Feline Oral Squamous Cell Carcinoma. Journal of the American Animal Hospital Association. 39(5). 463–467. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karri A. Meleo Breakdown of academic impact, for papers by M. Lagadic Breakdown of academic impact, for papers by Barbara C. Rütgen Breakdown of academic impact, for papers by Alexandra Malbon Breakdown of academic impact, for papers by D. Caliari Breakdown of academic impact, for papers by K. W. Head Breakdown of academic impact, for papers by Gerald W. Gough Breakdown of academic impact, for papers by Laura Dill Morton Breakdown of academic impact, for papers by Yeganeh Talebkhan Breakdown of academic impact, for papers by Shruthi Naik
Rankless by CCL
2026